RAD December 2021 Conference Abstracts and Posters
All accepted abstracts will be published in the British Journal of Dermatology.562 - The Psychosocial Burden Associated With and Effective Treatment Approach for Atopic Dermatitis: A Literature Review
Hira Ghani BA, Marielle Jamgochian MBS, Amy Pappert MD, Raphia Rahman MBS, Stefanie Cubelli
573 - Oral Difelikefalin Reduces Pruritus in Atopic Dermatitis
Brian S. Kim, MD, MTR; Masato Tamari, MD, PhD; Lydia Zamidar, BS; Kristine Nograles, MD; Catherine Munera, PhD; Joana Goncalves, MD; Emma Guttman-Yassky, MD, PhD; Mark Lebwohl, MD
575 - Tapinarof Cream 1% Once Daily for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults: the Pivotal Phase 3 ADORING Clinical Program
Lawrence F. Eichenfield, MD, Jonathan I. Silverberg, MD, PhD, MPH, Robert Bissonnette, MD, Anna M. Tallman, PharmD, Philip M. Brown, MD, JD, David S. Rubenstein, MD, PhD, Stephen C. Piscitelli, PharmD, John E. Jett, PhD
579 - Validation of a Spanish version of the ADCT (Atopic Dermatitis Control Tool) questionnaire for the assessment of disease control in patients with atopic dermatitis
Angles Maria Valeria, Caviedes Mariana Paula, Luna Paula Carolina, Terrasa Sergio, Vazquez Peña Fernando, Cristina Echeverría, Larralde Margarita, Mazzuoccolo Luis Daniel
583 - Divergent Paths: The Influence of Pediatric Atopic Dermatitis on Caregiver and Family Life Decisions
Korey Capozza, Jessica Lang, Alan Schwartz, Andrew Y Finlay
584 - Short-Term Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis Stratified by Age
Andrew Alexis, MD, MPH; Mette Deleuran, MD, DMSc; Jonathan I. Silverberg, MD, PhD, MPH; Melinda Gooderham, MSc, MD, FRCPC; Susan L. Johnson, MD, MS; Gary Chan, PharmD; Pinaki Biswas, PhD; Melissa Watkins, PhD
588 - Rates of Malignancies Among Patients with Moderate and Severe Atopic Dermatitis: A Retrospective Cohort Study
Monique M. Hedderson, Maryam M. Asgari, Fei Xu, Charles P. Quesenberry, Sneha Sridhar, Jamie Geier, Adina R. Lemeshow
596 - Dupilumab Monotherapy Provides Long-Term Control and Prevents Flares in Adults With Moderate-to-Severe Atopic Dermatitis Optimally Responding at Week 16
Andreas Wollenberg, Diamant Thaçi, Eric L. Simpson, Robert Bissonnette, Amy Praestgaard, Gerald Wilson, Ana B. Rossi
597 - Patient Well-being and Perception of Treatment Effect With Long-Term Dupilumab Monotherapy in Adults With Moderate-to-Severe Atopic Dermatitis
Eric L. Simpson, Stefan Beissert, Lisa A. Beck, Haixin Zhang, Kimberly Aamodt, Ana B. Rossi
598 - Dupilumab Provides Long-Term Efficacy Over 2.5 Years in Adults With Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck, Robert Bissonnette, Andreas Wollenberg, Eric L. Simpson, Diamant Thaçi, Amy Praestgaard, Kimberly Aamodt, Ana B. Rossi